Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.

Eli Lilly said its tirzepatide franchise had another stellar quarter.

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

Oral weight-loss medications could widen demand, but the bigger issue is whether coverage is becoming a must-have benefit or ...

The US FDA has proposed an end to most types of compounding of semaglutide, tirzepatide, and liraglutide. The agency said in a statement it has determined there is no longer a clinical need for ...

GLP-1 overdoses are on the rise, and some clinicians suggest informing patients of the risk in the initial consultation.

While GLP-1 medications first gained visibility for diabetes care and later for weight loss, researchers are now evaluating ...

By most measures, the new GLP-1 pills are underwhelming. Earlier this month, the pharmaceutical giant Eli Lilly debuted a weight-loss tablet that is far less effective than its po ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

A NEW two-in-one jab could be more effective than Wegovy and weight loss pills, as it targets “harmful” fat hidden deep ...

Dr. Cigdem Bas, Endocrinologist at Metabolic - the first clinic in the UAE to offer GLP-1 in tablet form - explains the role ...

A leading obesity medicine specialist says new oral GLP-1 drugs offer convenience but generally produce less weight loss than injectable versions like Ozempic. Pills may help patients reluctant to ...